Literature DB >> 74280

Carcinoma of the gallbladder or extrahepatic bile ducts: the role of radiotherapy.

S S Hanna, W D Rider.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 74280      PMCID： PMC1880449     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  LONG TERM SURVIVAL IN CARCINOMA OF THE GALLBLADDER.

Authors:  R M APPLEMAN; C G MORLOCK; D C DAHLIN; M A ADSON
Journal:  Surg Gynecol Obstet       Date:  1963-10

2.  Primary carcinoma of the gall bladder: presentation of seventy cases from the Rhode Island Hospital and a cumulative review of the last ten years of the American literature.

Authors:  G O STRAUCH
Journal:  Surgery       Date:  1960-03       Impact factor: 3.982

3.  Acute transient radiation hepatitis following whole abdominal irradiation.

Authors:  T H Kim; A M Panahon; M Friedman; J H Webster
Journal:  Clin Radiol       Date:  1976-10       Impact factor: 2.350

4.  Carcinoma of the gallbladder and extrahepatic biliary tree.

Authors:  F W Johnson; R B Gilsdorf
Journal:  Am Surg       Date:  1974-08       Impact factor: 0.688

5.  Radiosensitivity--what is it?

Authors:  W D Rider
Journal:  Laryngoscope       Date:  1971-07       Impact factor: 3.325

6.  Cancer of the common hepatic bile ducts--palliative radiotherapy.

Authors:  N Green; W P Mikkelsen; J A Kernen
Journal:  Radiology       Date:  1973-12       Impact factor: 11.105

7.  Malignant tumours of the bile-ducts.

Authors:  K W Warren; J C Mountain; W Lloyd-Jones
Journal:  Br J Surg       Date:  1972-07       Impact factor: 6.939

8.  Primary carcinoma of the gallbladder.

Authors:  R H Keill; M S DeWeese
Journal:  Am J Surg       Date:  1973-06       Impact factor: 2.565

9.  Carcinoma of the gall-bladder. A clinical appraisal and review of 57 cases.

Authors:  M J Solan; B T Jackson
Journal:  Br J Surg       Date:  1971-08       Impact factor: 6.939
  9 in total
  8 in total

1.  Postoperative chemoradiotherapy for gallbladder cancer.

Authors:  K Kim; E K Chie; J-Y Jang; S W Kim; S-W Han; D-Y Oh; S-A Im; T-Y Kim; Y-J Bang; S W Ha
Journal:  Strahlenther Onkol       Date:  2012-03-10       Impact factor: 3.621

2.  Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention.

Authors:  Y Fong; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

Review 3.  External beam plus intraoperative irradiation for gastrointestinal cancers.

Authors:  L L Gunderson; D M Nagorney; J A Martenson; J H Donohue; G R Garton; H Nelson; J Fieck
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

4.  Extrahepatic bile duct carcinoma: a case report.

Authors:  W Bethune; V Roux; J Anderson; V Scott; A L Goldson
Journal:  J Natl Med Assoc       Date:  1981-06       Impact factor: 1.798

Review 5.  Obstructive biliary tract disease.

Authors:  T T White
Journal:  West J Med       Date:  1982-06

6.  Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: a propensity score-matched Surveillance, Epidemiology, and End Results analysis.

Authors:  Omar Hyder; Rebecca M Dodson; Teviah Sachs; Matthew Weiss; Skye C Mayo; Michael A Choti; Christopher L Wolfgang; Joseph M Herman; Timothy M Pawlik
Journal:  Surgery       Date:  2013-07-19       Impact factor: 3.982

7.  Resection combined with intraoperative radiation therapy (IORT) for stage IV (TNM) gallbladder carcinoma.

Authors:  T Todoroki; Y Iwasaki; K Orii; M Otsuka; K Ohara; T Kawamoto; K Nakamura
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

8.  Trans-hepatic technique and intraluminal Pulsed Dose Rate (PDR-BT) brachytherapy in treatment of locally advanced bile duct and pancreas cancer.

Authors:  Janusz Skowronek; Aleksander Sowier; Paweł Skrzywanek
Journal:  J Contemp Brachytherapy       Date:  2009-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.